Trial Outcomes & Findings for Comparing Ways to Freeze the Nerve That Provides Thigh Sensation (NCT NCT02577510)
NCT ID: NCT02577510
Last Updated: 2017-09-15
Results Overview
The main outcome will be the total anesthesia-related time, defined as the sum of performance and onset times
COMPLETED
PHASE3
21 participants
less than 30 minutes
2017-09-15
Participant Flow
We enrolled 21 participants and randomized the sides for each modality.
Unit of analysis: sides
Participant milestones
| Measure |
Nerve Stimulation- Xylocaine Injection
Anesthesia of the lateral femoral cutaneous nerve using local anesthetic will be randomly assigned on the right or left side to receive nerve stimulation-xylocaine or ultrasound guided -xylocaine injections in all patients. One patient will therefore have both nerve stimulation AND ultrasound guided injections, only the side of the injection will be randomly assigned to one of the two modalities. Once one technique has been used to freeze one side, the other side will be frozen using the other technique.
Nerve Injection- Nerve Stimulator: For the neurostimulation nerve injection technique, the initial puncture site will be located medial to the anterosuperior iliac spine, just caudal to the inguinal ligament \[7\]. The 22-gauge insulated needle will be connected to a stimulator set at a current of 1.5 mA, a pulse width of 300 ms and a frequency of 2 Hz. A paresthesia referred to the lateral aspect of the thigh at a minimal stimulatory threshold of 0.6 mA (0.3ms) will be sought prior
|
Ultrasound Guided Xylocaine Injection
Nerve Injection - Ultrasound: For the ultrasound nerve injection group, after skin disinfection, the inguinal region of patients will be scanned using a high-frequency (6 to 13 MHz) linear array transducer covered with a sterile plastic cover. An ultrasound image showing the inguinal ligament and anterior superior iliac spine (ASIS) will be obtained. Using an out-of-plane technique, a 22-gauge nerve block needle will be inserted 1-2 cm medial to ASIS. The needle will be advanced unt
|
|---|---|---|
|
Overall Study
STARTED
|
21 21
|
21 21
|
|
Overall Study
COMPLETED
|
21 21
|
21 21
|
|
Overall Study
NOT COMPLETED
|
0 0
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Comparing Ways to Freeze the Nerve That Provides Thigh Sensation
Baseline characteristics by cohort
| Measure |
All Participants
n=21 Participants
|
|---|---|
|
Age, Continuous
|
40.3 years
STANDARD_DEVIATION 10.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
17 Participants
n=5 Participants
|
|
Region of Enrollment
Canada
|
21 Participants
n=5 Participants
|
|
BMI
|
26.7 kg/m^2
STANDARD_DEVIATION 3.5 • n=5 Participants
|
PRIMARY outcome
Timeframe: less than 30 minutesThe main outcome will be the total anesthesia-related time, defined as the sum of performance and onset times
Outcome measures
| Measure |
Nerve Stimulation
n=21 sides
|
Ultrasound
n=21 sides
|
|---|---|---|
|
Anesthesia Related Time
|
554 seconds
Standard Deviation 366.9
|
480 seconds
Standard Deviation 251.9
|
SECONDARY outcome
Timeframe: less than 30 minutespercentage of patients with successful block
Outcome measures
| Measure |
Nerve Stimulation
n=21 Participants
|
Ultrasound
n=21 Participants
|
|---|---|---|
|
Success Rate
|
16 Participants
|
20 Participants
|
SECONDARY outcome
Timeframe: less than 30 minuteshow often needle changes angle to make target
Outcome measures
| Measure |
Nerve Stimulation
n=21 sides
|
Ultrasound
n=21 sides
|
|---|---|---|
|
Needle Pass
|
9.5 attempts
Standard Deviation 12.2
|
3.2 attempts
Standard Deviation 2.9
|
SECONDARY outcome
Timeframe: less than 30 minutesvisual analogue scale- 0-10 - 0 is equal to no pain, while 10 is equal to maximum pain
Outcome measures
| Measure |
Nerve Stimulation
n=21 sides
|
Ultrasound
n=21 sides
|
|---|---|---|
|
Pain With Procedure
|
4.0 units on a scale
Standard Deviation 2.2
|
4.6 units on a scale
Standard Deviation 2.2
|
Adverse Events
Ultrasound Guided Xylocaine Injection
Nerve Stimulation Guided Xylocaine Injection
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Ultrasound Guided Xylocaine Injection
n=21 participants at risk
Adverse event collected for this side with this intervention.
|
Nerve Stimulation Guided Xylocaine Injection
n=21 participants at risk
Adverse event collected for this side with this intervention.
|
|---|---|---|
|
Nervous system disorders
Femoral Block
|
4.8%
1/21 • Number of events 1 • within 30 minutes post injection and 72 hours of injection
|
0.00%
0/21 • within 30 minutes post injection and 72 hours of injection
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place